This AHNS online physician locator helps you find a match for your medical needs.
Members: How to Modify your profile
- Go to the AHNS Member Panel and click the “Create/Edit Your Public Profile” link there.
- Members are encouraged to add social media handles, in order to be tagged on AHNS Instagram and Twitter pages. Both AHNS members and non members can view profiles
- Log into your membership account and update your profile and bio
- Having trouble accessing your account?
Instructions on using the search:
- The easiest way to search is to drag and zoom the map below until you are seeing your desired geographical area. Once there, click on the pins to see member information
- You may use the geosearch box to autocomplete an area and search that way
- If you wish to search by other criteria, use the text search box
Chase Heaton
UCSF
- 27
- 25
- 18
- 26
550 16th street
San Francisco, CA 94158
United States
Map It
Dr. Chase M. Heaton is a head and neck oncologic and reconstructive surgeon at the UCSF Helen Diller Family Comprehensive Cancer Center. He specializes in treating benign and malignant tumors of the oral cavity, oropharynx, larynx, thyroid, skin and salivary glands. He is fellowship trained in microvascular reconstruction and transoral robotic surgery.
In addition to treating patients, Dr. Heaton conducts clinical research on outcomes of head and neck surgery. He also plays an active role in teaching and mentoring UCSF otolaryngology residents and medical students. He is the Faculty Education Champion for the head and neck oncology resident rotation and is Course Director for the UCSF medical student selective.
Dr. Heaton completed undergraduate studies at the University of Notre Dame and earned a medical degree at the Stritch School of Medicine in Chicago. After finishing an otolaryngology-head and neck surgery residency at UCSF, he completed a one-year fellowship in head and neck oncology and microvascular reconstructive surgery at UCSF. He joined the UCSF faculty full-time in 2015.
Tavo With Electroporation, Pembrolizumab, and Epacadostat in Patients With Unresectable Head and Neck Cancer